Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings

By sjmartinez • June 3, 2024

LoVecchio F, McCarthy MW, Ye X, Henry AD, Doan QV, Lock JL, Riccobene T, Lyles RD, Talan DA. Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings. J Emerg Med. 2024 Mar 12:S0736-4679(24)00071-4. doi: 10.1016/j.jemermed.2024.03.003. Epub ahead of print. PMID: 38825531.

Tags: ABSSSI, Cost, Dalbavancin, Emergency Medicine, Long-acting antibiotic, Olive View DoM, Publications, Single-dose regimen

Hidden Webs and Small Bowel Obstruction: Non-steroidal Anti-inflammatory Drug (NSAID)-Induced Diaphragmatic Strictures

Harmon RL, Cheung N, Dietz R Jr, Chandna S, Fathizadeh P. Hidden Webs and Small Bowel Obstruction: Non-steroidal Anti-inflammatory Drug (NSAID)-Induced Diaphragmatic Strictures. Cureus. 2026[...]

Pembrolizumab and epigenetic modification with azacitidine reshapes the tumor microenvironment of platinum-resistant epithelial ovarian cancer: a phase 2 non-randomized clinical trial

Landon BV, Boland JL, Wahner Hendrickson AE, Armstrong DK, Winterhoff B, Wehr J, Annapragada AV, Cherry C, Balan A, Kaleka G, Velculescu VE, Baylin SB,[...]

Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene

Srinagesh HK, Gupta VK, Zhang A, Grunwald MR, Connor MP, Kota VK, Boccucci J, Ulrickson ML, Pradeep R, Hill LC, Tsai SB, O'Connor TE, Sandhu[...]